Abstract:Rumen-protected choline (RPC) supplementation in the periparturient period has in some instances prevented and alleviated fatty liver disease in dairy cows. Mechanistically, however, it is unclear how choline prevents the accumulation of lipid droplets (LD) in liver cells. In this study, primary liver cells isolated from liver tissue obtained via puncture biopsy from 3 nonpregnant midlactation multiparous Holstein cows (∼160 d postpartum) were used. Analyses of LD via oil red O staining, protein abundance via Western blotting, and phospholipid content and composition measured by thin-layer chromatography and HPLC/MC were performed in liver cells cultured in choline-deficient medium containing 150 μmol/L linoleic acid for 24 h. In a subsequent experiment, lipophagy was assessed in liver cells cultured with 30, 60 or 90 µmol/L choline-chloride. All data were analyzed statistically using SPSS 20.0 via t-tests or one-way ANOVA. Compared with liver cells cultured in DMEM medium alone, choline deficiency increased the average diameter of LD (1.59 µm vs. 2.10 µm), decreased the proportion of small LD (<2 µm) from 75.3% to 56.6%, and increased the proportion of large LD (>4 µm) from 5.6% to 15.0%. In addition, the speed of LD fusion was enhanced by the absence of choline. Among phospholipid species, the phosphatidylcholine (PC) content of liver cells decreased by 34.5%. Seventeen species of PC [PC (18:2_22:6), PC (15:0_16:1), PC (14:0_20:4), etc] and 6 species of LPC [LPC (15:0/0:0)], PC (22:2/0:0), LPC (20:2/0:0), etc] were decreased, while PC (14:1_16:1) and LPC (0:0/20:1) were increased. Choline deficiency increased the Triglyceride (TAG) content (0.57 μmol/mg vs. 0.39 μmol/mg) in liver cells and increased the protein abundance of sterol regulatory element binding protein 1 (SREBP1), sterol regulatory element binding protein cleavage activation protein (SCAP), and fatty acid synthase (FASN) by 23.5%, 17%, and 36.1%, respectively. Upon re-supplementation with choline, the phenotype of LD (TAG content, size, proportion, and phospholipid profile) was reversed, and the ratio of autophagy marker LC3II/LC3I protein was significantly upregulated in a dose-dependent manner. Overall, at least in vitro in midlactation cows, these data demonstrated that PC synthesis is necessary for normal LD formation and both rely on choline availability. According to the limitation of the source of liver cells used, further work should be conducted to ascertain that these effects are applicable to liver cells from postpartum cows, the physiological stage where the use of rumen-protected choline has been implemented for the prevention and treatment of fatty liver.

Characterization of Circulating Phosphatidylcholine Fatty Acids in Non‐pregnant Women with Supplemental DHA and Variable Choline Intake

Choline Intake Influences Phosphatidylcholine DHA Enrichment in Nonpregnant Women but Not in Pregnant Women in the Third Trimester.

Pregnancy Increases the Use of Choline Derived Methyl Groups for Phosphatidylcholine (PC) Production Through the PEMT Pathway with Subsequent Selective Transfer of PEMT‐PC to the Fetus

Pregnancy and Choline Intake Alter the Metabolic Use of Orally Consumed Choline in Women Consuming Deuterium Labeled Choline

Pregnancy Alters Choline Dynamics: Results of a Randomized Trial Using Stable Isotope Methodology in Pregnant and Nonpregnant Women.

Retraction: CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke.

Fetal Stress Markers Are Lowered by Maternal Choline Intakes Exceeding Recommendations

Choline Intakes Exceeding Recommendations During Human Lactation Improve Breast Milk Choline Content by Increasing PEMT Pathway Metabolites

Maternal Choline Intake Modulates Maternal and Fetal Biomarkers of Choline Metabolism in Humans

Choline Affects Placental Vascular Function and Development in a Dose Response Manner

Elevated Serum Phosphatidylcholine (16:1/22:6) Levels Promoted by Fish Oil and Vitamin D3 Are Highly Correlated with Biomarkers of Non-Alcoholic Fatty Liver Disease in Chinese Subjects.

A Higher Maternal Choline Intake Favorably Alters Placental Gene Expression of Biological Pathways Related to Disease Risk

Choline and Betaine Alter Fetal Brain Expression of Genes Related to Docosahexaenoic Acid Availability in A Mouse Model of Gestational Diabetes

Influence of Lactation and Choline Intake on One‐carbon Biomarkers in Women

Pure Omega 3 Polyunsaturated Fatty Acids (EPA, DPA or DHA) Are Associated with Increased Plasma Levels of 3-Carboxy-4-methyl-5-propyl-2-furanpropanoic Acid (CMPF) in a Short-Term Study in Women

Pregnancy Status and Choline Intake Alter DNA Integrity, Epigenetic Marks and Gene Expression

Effects of choline deficiency and supplementation on lipid droplet accumulation in bovine primary liver cells in vitro.

Evidence of multiple hepatic mechanisms to mobilize docosahexaenoic acid into dam plasma during pregnancy in chow-fed sprague dawley rats

The distribution of dietary choline intake and serum choline levels in Australian women during pregnancy and associated early life factors

Maternal N-3 Fatty Acid Supplementation Has an Immediate Impact on the Human Milk Fatty Acid Composition.

Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes